AstraZeneca
AZN
$76.41
Share price
0.70%
Change (1 day)
3.96%
Change (1 year)
Categories
AstraZeneca (AZN) Fails to deliver data
Key failure to deliver metrics for AstraZeneca:
- Last SEC data release: 2024-04-12
- Last 15 days FTD volume: $0.94 M
- Last 3 months FTD volume: $0.10 B
- Last year FTD volume: $0.17 B
Failures to deliver for AstraZeneca (AZN) - 3 months history
Number of shares, 3 months chartBiweekly Failures to deliver volume for AstraZeneca (AZN) - since 2013
Volume in USD (price x number of shares), data since 2013AstraZeneca (AZN) Failure to deliver volume, Year over Year
| Year | Volume (Price x Shares) | Change |
|---|---|---|
| 2024 | $0.10 B | -34.72% |
| 2023 | $0.16 B | -34.28% |
| 2022 | $0.25 B | -75.21% |
| 2021 | $1.01 B | 472.91% |
| 2020 | $0.17 B | -9% |
| 2019 | $0.19 B | -75.64% |
| 2018 | $0.80 B | 78.18% |
| 2017 | $0.44 B | -13.09% |
| 2016 | $0.51 B | 54.29% |
| 2015 | $0.33 B | -11.35% |
| 2014 | $0.37 B | 418.7% |
| 2013 | $72.84 M |
FTD volume in the last 3 months for similar companies or competitors
| Company | FTD volume (3months) | FTD volume (1 year) | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $0.14 B | $0.59 B | 🇺🇸 USA |
 Novartis NVS | $30.58 M | $84.43 M | 🇨🇭 Switzerland |
 Pfizer PFE | $16.08 M | $0.32 B | 🇺🇸 USA |
 Abbott Laboratories ABT | $62.38 M | $0.13 B | 🇺🇸 USA |
 Eli Lilly LLY | $53.06 M | $0.12 B | 🇺🇸 USA |
 Sanofi SNY | $26.39 M | $50.57 M | 🇫🇷 France |
 Biogen BIIB | $23.03 M | $76.93 M | 🇺🇸 USA |
 Merck MRK | $6 M | $0.17 B | 🇺🇸 USA |
 Bristol-Myers Squibb BMY | $0.23 B | $0.32 B | 🇺🇸 USA |
 GlaxoSmithKline GSK | $16.24 M | $23.04 M | 🇬🇧 UK |